all about digital currency- Top Knowledge

The turnover of Shanghai, Shenzhen and Beijing exceeded 1.5 trillion yuan, 52.2 billion yuan more than the previous day. Up to now, the turnover of Shanghai, Shenzhen and Beijing exceeded 1.5 trillion yuan, 52.2 billion yuan more than the previous day. Among them, the turnover of Shanghai Stock Exchange was 584.4 billion yuan, that of Shenzhen Stock Exchange was 899.8 billion yuan, and that of Beizheng 50 was 15.8 billion yuan.The European Central Bank cut interest rates by 25 basis points, warning that economic growth will slow down. The European Central Bank cut interest rates by 25 basis points to 3%, and warned that economic growth will be weaker than its previous forecast. This is the fourth time that the European Central Bank has cut interest rates since June, bringing the benchmark interest rate to its lowest level since March 2023. At the same time, the European Central Bank warned that the euro zone economy will only grow by 1.1% in 2025, lower than its forecast of 1.3% in September. It was widely expected that the European Central Bank would cut interest rates. Investors expect that the European Central Bank will cut interest rates more than the Federal Reserve next year, because it is widely expected that the economic growth of the euro zone will lag behind that of the United States. The euro zone's export-dependent economy is also vulnerable to Trump's threat to impose tariffs of up to 20% on all American imports.European Central Bank: It is estimated that the GDP growth rate will be 0.7% in 2024, 1.1% in 2025, 1.4% in 2026 and 1.3% in 2027. (It is expected to be 0.8%, 1.3% and 1.5% respectively in September) It is estimated that the core inflation rate will be 2.9% in 2024, 2.3% in 2025 and 1.9% in 2026. (It is expected to be 2.8%, 2.3% and 2.0% respectively in September) It is estimated that the core inflation rate will be 1.9% in 2027.

On December 11th, it was reported that the U.S. government was divided over the U.S. steel acquisition, and Biden considered blocking the transaction. It was reported that the U.S. Department of Defense, the Ministry of Finance and the State Council all believed that the Japanese Steel Company's $15 billion acquisition of American steel companies would not bring national security risks, but U.S. President Biden was expected to block the transaction. Earlier, some media quoted people familiar with the matter as saying that Biden planned to block the acquisition of American steel companies later this month on the grounds of national security. The Committee on Foreign Investment in the United States has been reviewing the proposed acquisition for most of this year, and the group must submit its decision to Biden before December 22 or 23.According to a poll released by The Israel Times recently, 66% of the Israeli respondents believe that Netanyahu should leave politics, and only 27% of the people support him.South Korea's finance ministers and Japan's finance ministers held an online meeting, and the two sides reiterated the importance of the partnership between the two countries.

The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)Japanese government bond futures rose, recovering some of the earlier declines.